Prolyl endopeptidase and dipeptidyl peptidase IV are associated with externalizing and aggressive behaviors in normal and autistic adolescents

Life Sciences

Volumn 136, Issue , 2015, Pages 157-162

  Frenssen, Floris ^a   Croonenberghs, Jan ^a   Van Den Steene, Helena ^a   Maes, Michael ^b,c,d  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b DEAKIN UNIVERSITY   (Australia)

^c CHULALONGKORN UNIVERSITY   (Thailand)

^d STATE UNIVERSITY OF LONDRINA   (Brazil)

Author keywords

Age; Autism; Behavior; DPP IV; Immunology; Pathophysiology; PEP; Peptidase activity

Indexed keywords

ALPHA 1 GLOBULIN; ALPHA 2 GLOBULIN; DIPEPTIDYL PEPTIDASE IV; IMMUNOGLOBULIN; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN G4; PROLYL ENDOPEPTIDASE; UNCLASSIFIED DRUG; DPP4 PROTEIN, HUMAN; SERINE PROTEINASE;

ADOLESCENT; ADOLESCENT BEHAVIOR; ADULT; AGE; AGGRESSION; ARTICLE; ATTENTION; AUTISM; BODY MASS; CHILD BEHAVIOR CHECKLIST; CLINICAL ARTICLE; CONTROLLED STUDY; DELINQUENCY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MALE; MIXED ANXIETY AND DEPRESSION; PSYCHOSOCIAL WITHDRAWAL; SOCIAL PROBLEM; BLOOD; CASE CONTROL STUDY; ENZYMOLOGY; PSYCHOLOGY; YOUNG ADULT;

ADOLESCENT; AGGRESSION; AUTISTIC DISORDER; CASE-CONTROL STUDIES; DIPEPTIDYL PEPTIDASE 4; HUMANS; MALE; SERINE ENDOPEPTIDASES; YOUNG ADULT;

EID: 84939441784     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2015.07.003     Document Type: Article

References (61)

1. A.J. Baxter, T.S. Brugha, H.E. Erskine, R.W. Scheurer, T. Vos, and J.G. Scott The epidemiology and global burden of autism spectrum disorders Psychol. Med. 2014 1 13 10.1017/S003329171400172X
2. M.-C. Lai, M.V. Lombardo, and S. Baron-Cohen Autism Lancet 383 2014 896 910 10.1016/S0140-6736(13)61539-1
3. A. Ronald, and R.A. Hoekstra Autism spectrum disorders and autistic traits: a decade of new twin studies Am. J. Med. Genet. B Neuropsychiatr. Genet. 156B 2011 255 274 10.1002/ajmg.b.31159
4. C. Onore, M. Careaga, and P. Ashwood The role of immune dysfunction in the pathophysiology of autism Brain Behav. Immun. 26 2012 383 392 10.1016/j.bbi.2011.08.007
5. X. Li, A. Chauhan, A.M. Sheikh, S. Patil, V. Chauhan, X.-M. Li, and et al. Elevated immune response in the brain of autistic patients J. Neuroimmunol. 207 2009 111 116 10.1016/j.jneuroim.2008.12.002
6. D.L. Vargas, C. Nascimbene, C. Krishnan, A.W. Zimmerman, and C.A. Pardo Neuroglial activation and neuroinflammation in the brain of patients with autism Ann. Neurol. 57 2005 67 81 10.1002/ana.20315
7. J.T. Morgan, G. Chana, C.A. Pardo, C. Achim, K. Semendeferi, J. Buckwalter, and et al. Microglial activation and increased microglial density observed in the dorsolateral prefrontal cortex in autism Biol. Psychiatry 68 2010 368 376 10.1016/j.biopsych.2010.05.024
8. J. Croonenberghs, E. Bosmans, D. Deboutte, G. Kenis, and M. Maes Activation of the inflammatory response system in autism Neuropsychobiology 45 2002 1 6 10.1159/000048665
9. J. Croonenberghs, A. Wauters, K. Devreese, R. Verkerk, S. Scharpe, E. Bosmans, and et al. Increased serum albumin, gamma globulin, immunoglobulin IgG, and IgG2 and IgG4 in autism Psychol. Med. 32 2002 1457 1463 10.1017/S0033291702006037
10. S.M. Gibney, and H.A. Drexhage Evidence for a dysregulated immune system in the etiology of psychiatric disorders J. NeuroImmune Pharmacol. 8 2013 900 920 10.1007/s11481-013-9462-8
11. H.O. Atladóttir, P. Thorsen, L. ∅stergaard, D.E. Schendel, S. Lemcke, M. Abdallah, and et al. Maternal infection requiring hospitalization during pregnancy and autism spectrum disorders J. Autism Dev. Disord. 40 2010 1423 1430 10.1007/s10803-010-1006-y
12. A.M. Depino Peripheral and central inflammation in autism spectrum disorders Mol. Cell. Neurosci. 53 2013 69 76 10.1016/j.mcn.2012.10.003
13. P.H. Patterson Immune involvement in schizophrenia and autism: etiology, pathology and animal models Behav. Brain Res. 204 2009 313 321 10.1016/j.bbr.2008.12.016
14. H.O. Atladóttir, M.G. Pedersen, P. Thorsen, P.B. Mortensen, B. Deleuran, W.W. Eaton, and et al. Association of family history of autoimmune diseases and autism spectrum disorders Pediatrics 124 2009 687 694 10.1542/peds.2008-2445
15. K.L. Reichelt, D. Tveiten, A.-M. Knivsberg, and G. Brønstad Peptides' role in autism with emphasis on exorphins Microb. Ecol. Health Dis. 23 2012 10.3402/mehd.v23i0.18958
16. C. Millward, M. Ferriter, S. Calver, and G. Connell-Jones Gluten- and casein-free diets for autistic spectrum disorder Cochrane Database Syst. Rev. 2008 10.1002/14651858.CD003498.pub3 (CD003498)
17. H. Cass, P. Gringras, J. March, I. McKendrick, A.E. O'Hare, L. Owen, and et al. Absence of urinary opioid peptides in children with autism Arch. Dis. Child. 93 2008 745 750 10.1136/adc.2006.114389
18. J. Gass, and C. Khosla Prolyl endopeptidases Cell. Mol. Life Sci. 64 2007 345 355 10.1007/s00018-006-6317-y
19. M. Maes, F. Goossens, S. Scharpé, H.Y. Meltzer, P. D'Hondt, and P. Cosyns Lower serum prolyl endopeptidase enzyme activity in major depression: further evidence that peptidases play a role in the pathophysiology of depression Biol. Psychiatry 35 1994 545 552 10.1016/0006-3223(94)90101-5
20. M. Maes, F. Goossens, S. Scharpé, J. Calabrese, R. Desnyder, and H.Y. Meltzer Alterations in plasma prolyl endopeptidase activity in depression, mania, and schizophrenia: effects of antidepressants, mood stabilizers, and antipsychotic drugs Psychiatry Res. 58 1995 217 225 10.1016/0165-1781(95)02698-V
21. M. Maes, I. Libbrecht, F. Van Hunsel, A.H. Lin, S. Bonaccorso, F. Goossens, and et al. Lower Serum Activity of Prolyl Endopeptidase in Fibromyalgia is Related to Severity of Depressive Symptoms and Pressure Hyperalgesia 1998 10.1017/S0033291798006801
22. M. Engel, T. Hoffmann, L. Wagner, M. Wermann, U. Heiser, R. Kiefersauer, and et al. The crystal structure of dipeptidyl peptidase IV (CD26) reveals its functional regulation and enzymatic mechanism Proc. Natl. Acad. Sci. U. S. A. 100 2003 5063 5068 10.1073/pnas.0230620100
23. M. Maes, I. De Meester, R. Verkerk, P. De Medts, A. Wauters, G. Vanhoof, and et al. Lower serum dipeptidyl peptidase IV activity in treatment resistant major depression: relationships with immune-inflammatory markers Psychoneuroendocrinology 22 1997 65 78 10.1016/S0306-4530(96)00040-6
24. S. Elgün, A. Keskinege, and H. Kumbasar Dipeptidyl peptidase IV and adenosine deaminase activity. Decrease in depression. Psychoneuroendocrinology 24 1999 823 832 10.1016/S0306-4530(99)00039-6
25. E. Emanuele, P. Minoretti, V. Martinelli, S. Pesenti, V. Olivieri, A. Aldeghi, and et al. Circulating levels of soluble CD26 are associated with phobic anxiety in women Prog. Neuro-Psychopharmacol. Biol. Psychiatry 30 2006 1334 1336 10.1016/j.pnpbp.2006.04.021
26. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders DSM-IV 4th ed. 1994 American Psychiatric Association
27. C. Lord, M. Rutter, and A.L. Couteur Autism diagnostic interview-revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders J. Autism Dev. Disord. 24 1994 659 685 10.1007/BF02172145
28. T.M. Achenbach Manual for the Child Behavior Checklist 1983 University of Vermont Department of Psychiatry
29. F. Goossens, I. De Meester, G. Vanhoof, and S. Scharpé A sensitive method for the assay of serum prolyl endopeptidase Eur. J. Clin. Chem. Clin. Biochem. 30 1992 235 238
30. T. Nagatsu, M. Hino, H. Fuyamada, T. Hayakawa, and S. Sakakibara New chromogenic substrates for X-prolyl dipeptidyl-aminopeptidase Anal. Biochem. 74 1976 466 476 10.1016/0003-2697(76)90227-X
31. M. Maes, S. Scharpé, I. De Meester, P. Goossens, A. Wauters, H. Neels, and et al. Components of biological variation in prolyl endopeptidase and dipeptidyl-peptidase IV activity in plasma of healthy subjects Clin. Chem. 40 1994 1686 1691
32. N. Momeni, B.M. Nordström, V. Horstmann, H. Avarseji, and B.V. Sivberg Alterations of prolyl endopeptidase activity in the plasma of children with autistic spectrum disorders BMC Psychiatry 5 2005 27 10.1186/1471-244X-5-27
33. L.C. Hunter, A. O'Hare, W.J. Herron, L.A. Fisher, and G.E. Jones Opioid peptides and dipeptidyl peptidase in autism Dev. Med. Child Neurol. 45 2003 121 128 10.1017/S0012162204210581
34. C.J. McDougle, C.A. Erickson, K.A. Stigler, and D.J. Posey Neurochemistry in the pathophysiology of autism J. Clin. Psychiatry 66 2005 9 18
35. M. Kosfeld, M. Heinrichs, P.J. Zak, U. Fischbacher, and E. Fehr Oxytocin increases trust in humans Nature 435 2005 673 676 10.1038/nature03701
36. G. Domes, M. Heinrichs, A. Michel, C. Berger, and S.C. Herpertz Oxytocin improves "mind-reading" in humans Biol. Psychiatry 61 2007 731 733 10.1016/j.biopsych.2006.07.015
37. R.R. Thompson, K. George, J.C. Walton, S.P. Orr, and J. Benson Sex-specific influences of vasopressin on human social communication Proc. Natl. Acad. Sci. U. S. A. 103 2006 7889 7894 10.1073/pnas.0600406103
38. E.F. Coccaro, R.J. Kavoussi, R.L. Hauger, T.B. Cooper, and C.F. Ferris Cerebrospinal fluid vasopressin levels: correlates with aggression and serotonin function in personality-disordered subjects Arch. Gen. Psychiatry 55 1998 708 714 10.1001/archpsyc.55.8.708
39. R. Lee, C. Ferris, L.D. Van de Kar, and E.F. Coccaro Cerebrospinal fluid oxytocin, life history of aggression, and personality disorder Psychoneuroendocrinology 34 2009 1567 1573 10.1016/j.psyneuen.2009.06.002
40. A. Campbell, and M. Hausmann Effects of oxytocin on women's aggression depend on state anxiety Aggress. Behav. 39 2013 316 322 10.1002/ab.21478
41. A.I. Malik, C.C. Zai, Z. Abu, B. Nowrouzi, and J.H. Beitchman The role of oxytocin and oxytocin receptor gene variants in childhood-onset aggression Genes Brain Behav. 11 2012 545 551 10.1111/j.1601-183X.2012.00776.x
42. E.F. Coccaro, R. Lee, T. Liu, and A.A. Mathé Cerebrospinal fluid neuropeptide Y-like immunoreactivity correlates with impulsive aggression in human subjects Biol. Psychiatry 72 2012 997 1003 10.1016/j.biopsych.2012.07.029
43. E.F. Coccaro, R. Lee, M.J. Owens, B. Kinkead, and C.B. Nemeroff Cerebrospinal fluid substance P-like immunoreactivity correlates with aggression in personality disordered subjects Biol. Psychiatry 72 2012 238 243 10.1016/j.biopsych.2012.02.023
44. L.Y. Al-Ayadhi Altered oxytocin and vasopressin levels in autistic children in Central Saudi Arabia Neurosciences 10 2005 47 50
45. C. Modahl, L. Green, D. Fein, M. Morris, L. Waterhouse, C. Feinstein, and et al. Plasma oxytocin levels in autistic children Biol. Psychiatry 43 1998 270 277 10.1016/S0006-3223(97)00439-3
46. A. Alabdali, L. Al-Ayadhi, and A. El-Ansary Association of social and cognitive impairment and biomarkers in autism spectrum disorders J. Neuroinflammation 11 2014 4 10.1186/1742-2094-11-4
47. M. Miller, K.L. Bales, S.L. Taylor, J. Yoon, C.M. Hostetler, C.S. Carter, and et al. Oxytocin and vasopressin in children and adolescents with autism spectrum disorders: sex differences and associations with symptoms Autism Res. 6 2013 91 102 10.1002/aur.1270
48. J.D. Jacobson, K.A. Ellerbeck, K.A. Kelly, K.K. Fleming, T.R. Jamison, C.W. Coffey, and et al. Evidence for alterations in stimulatory G proteins and oxytocin levels in children with autism Psychoneuroendocrinology 40 2014 159 169 10.1016/j.psyneuen.2013.11.014
49. C. Durinx, H. Neels, J.C. Van der Auwera, K. Naelaerts, S. Scharpe, and I. De Meester Reference values for plasma dipeptidyl-peptidase IV activity and their association with other laboratory parameters Clin. Chem. Lab. Med. 39 2001 155 159 10.1515/CCLM.2001.026
50. M. Maes, H.Y. Meltzer, S. Scharpé, E. Bosmans, E. Suy, I. De Meester, and et al. Relationships between lower plasma l-tryptophan levels and immune-inflammatory variables in depression Psychiatry Res. 49 1993 151 165 10.1016/0165-1781(93)90102-M
51. M. Maes, I. De Meester, G. Vanhoof, S. Scharpé, E. Bosmans, C. Vandervorst, and et al. Decreased serum dipeptidyl peptidase IV activity in major depression Biol. Psychiatry 30 1991 577 586 10.1016/0006-3223(91)90027-J
52. A.R. Van Gool, H.H. Van Ojik, W.H.J. Kruit, P.G.H. Mulder, D. Fekkes, M. Bannink, and et al. Serum activity of prolyl endopeptidase, but not of dipeptidyl peptidase IV, is decreased by immunotherapy with IFN-alpha in high-risk melanoma patients J. Interf. Cytokine Res. 24 2004 411 415 10.1089/1079990041535629
53. J. Zhong, X. Rao, and S. Rajagopalan An emerging role of dipeptidyl peptidase 4 (DPP4) beyond glucose control: potential implications in cardiovascular disease Atherosclerosis 226 2013 305 314 10.1016/j.atherosclerosis.2012.09.012
54. S. Garthus-Niegel, K.A. Hagtvet, and M.E. Vollrath A prospective study of weight development and behavior problems in toddlers: the Norwegian Mother and Child Cohort Study BMC Public Health 10 2010 626 10.1186/1471-2458-10-626
55. G. Hasler, D.S. Pine, A. Gamma, G. Milos, V. Ajdacic, D. Eich, and et al. The associations between psychopathology and being overweight: a 20-year prospective study Psychol. Med. 34 2004 1047 1057 10.1017/S0033291703001697
56. R.H. Bradley, R. Houts, P.R. Nader, M. O'Brien, J. Belsky, and R. Crosnoe The relationship between body mass index and behavior in children J. Pediatr. 153 2008 629 634 10.1016/j.jpeds.2008.05.026
57. S.E. Anderson, X. He, S. Schoppe-Sullivan, and A. Must Externalizing behavior in early childhood and body mass index from age 2 to 12 years: longitudinal analyses of a prospective cohort study BMC Pediatr. 10 2010 49 10.1186/1471-2431-10-49
58. J.C. Lumeng, K. Gannon, H.J. Cabral, D.A. Frank, and B. Zuckerman Association between clinically meaningful behavior problems and overweight in children Pediatrics 112 2003 1138 1145 10.1542/peds.112.5.1138
59. M. Siervo, D. Ruggiero, R. Sorice, T. Nutile, M. Aversano, M. Iafusco, and et al. Body mass index is directly associated with biomarkers of angiogenesis and inflammation in children and adolescents Nutrition 28 2012 262 266 10.1016/j.nut.2011.06.007
60. J.B. Dowd, A. Zajacova, and A.E. Aiello Predictors of inflammation in U.S. children aged 3-16 years Am. J. Prev. Med. 39 2010 314 320 10.1016/j.amepre.2010.05.014
61. N. Slopen, L.D. Kubzansky, and K.C. Koenen Internalizing and externalizing behaviors predict elevated inflammatory markers in childhood Psychoneuroendocrinology 38 2013 2854 2862 10.1016/j.psyneuen.2013.07.012